{"id":"https://openalex.org/W4388047904","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0718","title":"718 Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies","display_name":"718 Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388047904","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0718"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0718","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0718","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0718","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/813.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/813.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002887876","display_name":"Benjamin Garmezy","orcid":"https://orcid.org/0000-0003-2790-6235","observed_orcids":["https://orcid.org/0000-0003-2790-6235"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Garmezy","raw_affiliation_strings":["Sarah Cannon Cancer Institute Nashville, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Cancer Institute Nashville, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012169173","display_name":"Swetha Kambhampati","orcid":"https://orcid.org/0000-0002-4783-2643","observed_orcids":["https://orcid.org/0000-0002-4783-2643","https://orcid.org/0000-0002-5776-3274"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Swetha Kambhampati","raw_affiliation_strings":["City of Hope, Duarte, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Duarte, CA, USA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029588412","display_name":"Brendan D. Curti","orcid":"https://orcid.org/0000-0003-3948-2708","observed_orcids":["https://orcid.org/0000-0003-3948-2708"]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brendan Curti","raw_affiliation_strings":["Providence Cancer Institute, Franz Clinic, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Providence Cancer Institute, Franz Clinic, Portland, OR, USA","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033671689","display_name":"Melissa Andrea Reimers","orcid":"https://orcid.org/0000-0002-5167-3630","observed_orcids":["https://orcid.org/0000-0002-5167-3630"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Reimers","raw_affiliation_strings":["Washington University in St. Louis, St Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St. Louis, St Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016048836","display_name":"Paolo Fabrizio Caimi","orcid":"https://orcid.org/0000-0003-1436-0464","observed_orcids":["https://orcid.org/0000-0003-1436-0464"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paolo Caimi","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014995908","display_name":"Catherine Diefenbach","orcid":"https://orcid.org/0000-0003-1116-3246","observed_orcids":["https://orcid.org/0000-0003-1116-3246"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Diefenbach","raw_affiliation_strings":["New York University Langone School of Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University Langone School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000198604","display_name":"Elisabeth I. Heath","orcid":"https://orcid.org/0000-0003-1381-2713","observed_orcids":["https://orcid.org/0000-0003-1381-2713"]},"institutions":[{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisabeth Heath","raw_affiliation_strings":["Karmanos Cancer Institute, Detroit, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karmanos Cancer Institute, Detroit, MI, USA","institution_ids":["https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007689146","display_name":"Eric W. Jonasch","orcid":"https://orcid.org/0000-0003-0943-2806","observed_orcids":["https://orcid.org/0000-0003-0943-2806"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Jonasch","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016051881","display_name":"Stephen Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Park","raw_affiliation_strings":["Levine Cancer Institute, Charlotte, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Levine Cancer Institute, Charlotte, NC, USA","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061052702","display_name":"Noah Saul Kornblum","orcid":"https://orcid.org/0000-0001-5985-2011","observed_orcids":["https://orcid.org/0000-0001-5985-2011"]},"institutions":[{"id":"https://openalex.org/I1335289525","display_name":"Montefiore Medical Center","ror":"https://ror.org/044ntvm43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335289525","https://openalex.org/I19772626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noah Kornblum","raw_affiliation_strings":["Montefiore Medical Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Montefiore Medical Center, New York, NY, USA","institution_ids":["https://openalex.org/I1335289525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100369292","display_name":"Weidong Li","orcid":"https://orcid.org/0000-0003-0521-7412","observed_orcids":["https://orcid.org/0000-0003-0521-7412"]},"institutions":[{"id":"https://openalex.org/I4210153921","display_name":"Guangzhou Medical University Cancer Hospital","ror":"https://ror.org/046c18a90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153921"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Weidong Li","raw_affiliation_strings":["Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China","institution_ids":["https://openalex.org/I4210153921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100369021","display_name":"Ning Li","orcid":"https://orcid.org/0000-0002-3945-2536","observed_orcids":["https://orcid.org/0000-0002-3945-2536"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ning Li","raw_affiliation_strings":["Chinese Academy of Medical Sciences, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chinese Academy of Medical Sciences, Beijing, China","institution_ids":["https://openalex.org/I200296433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003766253","display_name":"Stephen E. F. Spurgeon","orcid":"https://orcid.org/0000-0001-9962-438X","observed_orcids":["https://orcid.org/0000-0001-9962-438X"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Spurgeon","raw_affiliation_strings":["Oregon Health and Sciences University, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Sciences University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073593424","display_name":"Ulka N. Vaishampayan","orcid":"https://orcid.org/0000-0001-5800-4571","observed_orcids":["https://orcid.org/0000-0001-5800-4571"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ulka N Vaishampayan","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101763455","display_name":"Dingwei Ye","orcid":"https://orcid.org/0000-0002-5683-0260","observed_orcids":["https://orcid.org/0000-0002-5683-0260"]},"institutions":[{"id":"https://openalex.org/I4210093194","display_name":"Fudan University Shanghai Cancer Center","ror":"https://ror.org/00my25942","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093194"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dingwei Ye","raw_affiliation_strings":["Fudan University Shanghai Cancer Center, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fudan University Shanghai Cancer Center, Shanghai, China","institution_ids":["https://openalex.org/I4210093194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100425464","display_name":"Li Zhang","orcid":"https://orcid.org/0000-0001-8719-4407","observed_orcids":["https://orcid.org/0000-0001-8719-4407"]},"institutions":[{"id":"https://openalex.org/I4210146711","display_name":"Sun Yat-sen University Cancer Center","ror":"https://ror.org/0400g8r85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146711"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Li Zhang","raw_affiliation_strings":["Sun Yat-Sen University Cancer Center, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sun Yat-Sen University Cancer Center, Guangzhou, China","institution_ids":["https://openalex.org/I4210146711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069739901","display_name":"Weili Zhao","orcid":"https://orcid.org/0000-0002-6834-1616","observed_orcids":["https://orcid.org/0000-0002-6834-1616"]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I2801556517","display_name":"Ruijin Hospital","ror":"https://ror.org/01hv94n30","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801556517"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Weili Zhao","raw_affiliation_strings":["Ruijin Hospital-Shanghai Jiaotong University School of Medicine, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ruijin Hospital-Shanghai Jiaotong University School of Medicine, Shanghai, China","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2801556517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100449751","display_name":"Zhu Chen","orcid":"https://orcid.org/0000-0002-9974-0716","observed_orcids":["https://orcid.org/0000-0002-9974-0716","https://orcid.org/0000-0001-8827-3342"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhu Chen","raw_affiliation_strings":["ProfoundBio (Suzhou), Suzhou, Jiangsu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProfoundBio (Suzhou), Suzhou, Jiangsu, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067778266","display_name":"Naomi N. H. Hunder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naomi Hunder","raw_affiliation_strings":["ProfoundBio US Co., Woodinville, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProfoundBio US Co., Woodinville, WA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009784472","display_name":"Sharon Ma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon Ma","raw_affiliation_strings":["ProfoundBio US Co., Woodinville, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProfoundBio US Co., Woodinville, WA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eric Song","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Song","raw_affiliation_strings":["ProfoundBio US Co., Woodinville, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProfoundBio US Co., Woodinville, WA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053257668","display_name":"Justin Call","orcid":"https://orcid.org/0000-0001-8227-7406","observed_orcids":["https://orcid.org/0000-0001-8227-7406"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin A Call","raw_affiliation_strings":["START Mountain Region, West Valley City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"START Mountain Region, West Valley City, UT, USA","institution_ids":["https://openalex.org/I4210119066"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":21,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A813","last_page":"A813"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cd70","display_name":"CD70","score":0.9950000047683716},{"id":"https://openalex.org/keywords/exatecan","display_name":"exatecan","score":0.9900000095367432},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8500000238418579},{"id":"https://openalex.org/keywords/hydrophilic-linkers","display_name":"hydrophilic linkers","score":0.9100000262260437},{"id":"https://openalex.org/keywords/protease-cleavable-linker","display_name":"protease-cleavable linker","score":0.8629999756813049},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.8360000252723694},{"id":"https://openalex.org/keywords/nasopharyngeal-carcinoma","display_name":"nasopharyngeal carcinoma","score":0.949999988079071},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7210000157356262},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9810000061988831},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7599999904632568},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8399999737739563},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9869999885559082}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5233458876609802},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5111201405525208},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5000388622283936},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.49935078620910645},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.49428772926330566},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.49124401807785034},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4839487373828888},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.4807693660259247},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.47721606492996216},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3462601900100708},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3252369165420532},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24873873591423035},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.19185665249824524}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0718","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0718","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0718","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/813.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:76bf6cfb9a414feeb1aa4885de183aec","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/76bf6cfb9a414feeb1aa4885de183aec","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0718","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0718","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0718","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/813.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.979200005531311,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388047904.pdf","grobid_xml":"https://content.openalex.org/works/W4388047904.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386086608","https://openalex.org/W4282970098","https://openalex.org/W4282969264","https://openalex.org/W4388070826","https://openalex.org/W4365512287","https://openalex.org/W4379282892","https://openalex.org/W4282927991","https://openalex.org/W4362534529","https://openalex.org/W4393075770","https://openalex.org/W4200320387"],"abstract_inverted_index":{"Background":[0],"PRO1160":[1,31,119,139,164,226,286,324],"is":[2,16,76,90,97,101,120,165,209,287,384],"a":[3,34,42,50,70,103,181,296],"novel":[4],"antibody-drug":[5],"conjugate":[6],"(ADC)":[7],"directed":[8],"to":[9,78,216,269,317,326,423],"CD70,":[10,40],"an":[11,210],"antigen":[12],"mediating":[13],"immuno-suppression":[14],"that":[15,58],"overexpressed":[17],"in":[18,28,93,123,145,167,178,185,193,227,250,283,389,395],"multiple":[19],"solid":[20],"tumors":[21],"and":[22,47,66,75,100,115,135,159,169,196,204,222,299,321,325,334,349,352,365,375,417],"hematologic":[23],"malignancies,":[24],"with":[25,201,229,392],"limited":[26],"distribution":[27],"normal":[29],"tissues.":[30],"comprises":[32],"(1)":[33],"human":[35],"monoclonal":[36],"antibody":[37,177],"specific":[38],"for":[39,85,259,311],"(2)":[41],"protease-cleavable":[43],"proprietary":[44],"hydrophilic":[45,60],"linker,":[46],"(3)":[48],"exatecan,":[49],"topoisomerase":[51],"1":[52,294],"inhibitor.":[53],"Comprehensive":[54],"prior":[55,422],"work":[56],"demonstrated":[57],"the":[59,175,188,194,218,246,256,278,284,319,328,371,390],"linker":[61],"confers":[62],"excellent":[63],"physicochemical":[64],"properties":[65],"pharmacokinetics":[67],"(PK)":[68],"across":[69],"range":[71],"of":[72,105,127,149,225,295,323,343],"payload":[73],"mechanisms":[74],"superior":[77],"conventional":[79],"linkers":[80],"on":[81,292],"these":[82],"critical":[83],"parameters":[84],"ADCs.":[86],"In":[87,180],"addition,":[88],"exatecan":[89,202],"broadly":[91],"active":[92],"many":[94],"tumor":[95,151],"types,":[96],"membrane":[98],"permeable,":[99],"not":[102,281],"substrate":[104],"multidrug":[106],"resistance":[107],"pumps,":[108],"thus":[109],"likely":[110],"lending":[111],"strong":[112],"bystander":[113],"effects":[114],"durable":[116],"treatment":[117,300],"responses.":[118],"highly":[121],"potent":[122],"cell-derived":[124],"xenograft":[125,147],"models":[126,148],"renal":[128],"cell":[129],"carcinoma":[130,137],"(RCC),":[131],"non-Hodgkin":[132],"lymphoma":[133],"(NHL),":[134],"nasopharyngeal":[136],"(NPC).":[138],"also":[140,263,379],"demonstrates":[141],"marked":[142],"antitumor":[143,223,376],"activity":[144,224,377],"patient-derived":[146],"diverse":[150],"sites,":[152],"histologies,":[153],"molecular":[154],"subtypes,":[155],"target":[156],"expression":[157],"levels,":[158],"Epstein":[160],"Barr":[161],"Virus":[162],"status.":[163],"stable":[166],"circulation":[168],"displays":[170],"PK":[171],"characteristics":[172],"indistinguishable":[173],"from":[174],"parent":[176],"rats.":[179],"GLP":[182],"toxicity":[183,191],"study":[184,215,341,383,407],"cynomolgus":[186],"monkeys,":[187],"primary":[189,314],"PRO1160-related":[190],"resided":[192],"thymus":[195],"bone":[197],"marrow,":[198],"was":[199,205],"consistent":[200],"toxicities,":[203],"reversible.":[206],"Methods":[207],"PRO1160\u2013001":[208],"ongoing,":[211],"open-label":[212],"Phase":[213],"1/2":[214],"evaluate":[217,318],"safety,":[219],"tolerability,":[220],"PK,":[221,373],"patients":[228],"metastatic":[230,232,361],"RCC,":[231,360],"or":[233,236,255,280,308,362],"relapsed":[234,363],"NPC,":[235,364],"advanced":[237,366],"relapsed/refractory":[238,367],"NHL.":[239,260],"Patients":[240,261],"must":[241,262],"have":[242,264],"measurable":[243],"disease":[244,304],"per":[245],"Response":[247],"Evaluation":[248],"Criteria":[249],"Solid":[251],"Tumors":[252],"(RECIST)":[253],"1.1":[254],"Lugano":[257],"Classification":[258],"previously":[265],"received":[266],"therapies":[267],"known":[268],"confer":[270],"clinical":[271],"benefit":[272],"unless":[273],"considered":[274],"ineligible,":[275],"refused":[276],"by":[277,289],"patient,":[279],"available":[282],"region.":[285],"given":[288],"intravenous":[290],"infusion":[291],"Day":[293],"21-day":[297],"cycle":[298],"may":[301],"continue":[302],"until":[303],"progression,":[305],"unacceptable":[306],"toxicity,":[307],"other":[309],"reason":[310],"discontinuation.":[312],"The":[313,382,406],"objectives":[315],"are":[316],"safety":[320],"tolerability":[322],"identify":[327],"maximum":[329],"tolerated":[330],"dose,":[331],"if":[332],"reached,":[333],"recommended":[335],"phase":[336],"2":[337,344],"dose":[338],"(RP2D).":[339],"This":[340],"consists":[342],"parts,":[345],"Part":[346,353],"A:":[347],"dose-escalation":[348],"dose-level":[350],"expansion,":[351],"B:":[354],"3":[355],"tumor-specific":[356],"expansion":[357],"cohorts":[358],"(metastatic":[359],"NHL)":[368],"treated":[369],"at":[370,387],"RP2D.":[372],"immunogenicity,":[374],"will":[378],"be":[380],"evaluated.":[381],"currently":[385],"enrolling":[386],"sites":[388],"US,":[391],"future":[393],"enrollment":[394],"China":[396],"planned":[397],"(Clinicaltrials.gov:":[398],"NCT05721222).":[399],"Trial":[400],"Registration":[401],"Clinicaltrials.gov":[402],"NCT05721222":[403],"Ethics":[404],"Approval":[405],"obtained":[408],"ethics":[409],"approval":[410],"(WCG":[411],"Institutional":[412],"Review":[413],"Board;":[414],"ID":[415],"20230476)":[416],"participants":[418],"gave":[419],"informed":[420],"consent":[421],"taking":[424],"part.":[425]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}